Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Martin Kreller"'
Autor:
Santiago Andrés Brühlmann, Martin Walther, Magdalena Kerstin Blei, Constantin Mamat, Klaus Kopka, Robert Freudenberg, Martin Kreller
Publikováno v:
EJNMMI Radiopharmacy and Chemistry, Vol 9, Iss 1, Pp 1-22 (2024)
Abstract Background In recent years, targeted alpha therapy has gained importance in the clinics, and in particular, the alpha-emitter 225Ac plays a fundamental role in this clinical development. Nevertheless, depending on the chelating system no rea
Externí odkaz:
https://doaj.org/article/77ffd4f08c9b45cc8d911bdb6fedb0e9
Publikováno v:
EJNMMI Radiopharmacy and Chemistry, Vol 9, Iss 1, Pp 1-16 (2024)
Abstract Background There are only a handful of true theranostic matched pairs, and in particular the theranostic radiocopper trio 61Cu, 64Cu and 67Cu, for diagnosis and therapy respectively, is a very attractive candidate. In fact, the alternative o
Externí odkaz:
https://doaj.org/article/ed13beb721a54725a525c9fa3a2b9c64
Publikováno v:
Instruments, Vol 8, Iss 1, p 10 (2024)
A new Center for Radiopharmaceutical Cancer Research was established at the Helmholtz-Zentrum Dresden-Rossendorf in 2017 to centralize radionuclide and radiopharmaceutical production, as well as enable chemical and biochemical research. Routine produ
Externí odkaz:
https://doaj.org/article/faa941ad03cf470da2d89f89f8d5e9c4
Autor:
Santiago Andrés Brühlmann, Martin Walther, Martin Kreller, Falco Reissig, Hans-Jürgen Pietzsch, Torsten Kniess, Klaus Kopka
Publikováno v:
Pharmaceuticals, Vol 16, Iss 2, p 314 (2023)
Theranostic matched pairs of radionuclides have aroused interest during the last couple of years, and in that sense, copper is one element that has a lot to offer, and although 61Cu and 64Cu are slowly being established as diagnostic radionuclides fo
Externí odkaz:
https://doaj.org/article/81e626fb223d4ae986ac978a77c95224
Autor:
Santiago Andrés Brühlmann, Martin Kreller, Hans-Jürgen Pietzsch, Klaus Kopka, Constantin Mamat, Martin Walther, Falco Reissig
Publikováno v:
Pharmaceuticals, Vol 15, Iss 10, p 1167 (2022)
Targeted Alpha Therapy is a research field of highest interest in specialized radionuclide therapy. Over the last decades, several alpha-emitting radionuclides have entered and left research topics towards their clinical translation. Especially, 225A
Externí odkaz:
https://doaj.org/article/e1bd40fef1c94cd9bfea8361bca86f00
Autor:
Falco Reissig, David Bauer, Martin Ullrich, Martin Kreller, Jens Pietzsch, Constantin Mamat, Klaus Kopka, Hans-Jürgen Pietzsch, Martin Walther
Publikováno v:
Pharmaceuticals, Vol 13, Iss 10, p 272 (2020)
Barium-131 is a single photon emission computed tomography (SPECT)-compatible radionuclide for nuclear medicine and a promising diagnostic match for radium-223/-224. Herein, we report on the sufficient production route 133Cs(p,3n)131Ba by using 27.5
Externí odkaz:
https://doaj.org/article/d47137eec1fc4101b331b6b8c56d1e9f
Autor:
Martin Kreller, Hans Jürgen Pietzsch, Martin Walther, Henrik Tietze, Peter Kaever, Torsten Knieß, Frank Füchtner, Jörg Steinbach, Stephan Preusche
Publikováno v:
Instruments, Vol 3, Iss 1, p 9 (2019)
A new Center for Radiopharmaceutical Cancer Research was established at the Helmholtz-Zentrum Dresden-Rossendorf in order to centralize radionuclide production, radiopharmaceutical production and the chemical and biochemical research facilities. The
Externí odkaz:
https://doaj.org/article/b38773291a814f508bc42831b38fb35f